vimarsana.com

Page 14 - ஆராய்ச்சியாளர்கள் இல் ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus Live Updates: Oxford halts dosing in trial of AstraZeneca COVID-19 vaccine in children

Economic Times | 07 Apr, 2021 | 09.06AM IST Coronavirus Live Updates: India breaches 1-lakh COVID cases mark for the second time in three days The next four weeks, according to the Centre, are critical. It has however refused to open jabs for all above 18 years. ! 08:59 AM In Punjab, 80% of cases are due to the UK variant of COVID-19. This has been confirmed by genome sequencing. The increase in cases is event-driven like large weddings, local body elections, farmer protest, etc could have a role in it - Union Health Minister Dr Harsh Vardhan 08:47 AM 08:46 AM 08:45 AM As India records over 1.07 lakh new COVID cases in single day for first time, Centre says next 4 weeks very very critical

Oxford researchers pause trial of COVID-19 vaccine in children, teenagers

© Getty Images Researchers at Oxford University have paused a small pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca. In a statement, the university said it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA). An Oxford spokesperson said there are no safety concerns concerning the pediatric research, but the trial is paused while they await additional information from MHRA, which is reviewing possible links between the vaccine and rare blood clots in adults. ADVERTISEMENT The trial is testing the effectiveness of the vaccine in up to 300 children between the ages of 6 and 17.

Oxford halts dosing in trial of AstraZeneca COVID vaccine in children, teenagers

Oxford halts dosing in trial of AstraZeneca COVID vaccine in children, teenagers ANI | Updated: Apr 07, 2021 06:15 IST Oxford [UK], April 7, (ANI): Researchers at Oxford University have paused an ongoing pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca. In an official statement, the university said that it is awaiting the results of a safety review from UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA), as reported by the Hill. An Oxford spokesperson said there are no safety concerns concerning the pediatric research, but the trial is paused while they await additional information from MHRA, which is reviewing possible links between the vaccine and rare blood clots in adults, the spokesperson added.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.